What causes an egg to split in embryogenesis?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 29, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Timing of Egg Splitting in Embryogenesis Determines Twin Type

The timing of egg splitting after fertilization determines the type of monozygotic twins that develop, with earlier splitting (1-3 days) resulting in dichorionic-diamniotic twins, splitting at 4-8 days resulting in monochorionic-diamniotic twins, and later splitting (8-13 days) resulting in monochorionic-monoamniotic twins. 1

Mechanism of Egg Splitting

Monozygotic twinning occurs when a single fertilized egg (zygote) splits into two separate embryos. The timing of this split is crucial:

  • 1-3 days after fertilization: When the split occurs during the early morula stage (within 4 days of fertilization), it results in dichorionic-diamniotic twins with two separate placentas and amniotic sacs 1

  • 4-8 days after fertilization: When the split occurs at the blastocyst stage, it results in monochorionic-diamniotic twins with a single shared placenta but two amniotic sacs 1

  • 8-13 days after fertilization: When the split occurs later, it results in monochorionic-monoamniotic twins with a shared placenta and a single amniotic sac 1

  • >13 days after fertilization: Very late splitting (beyond 13 days) results in conjoined twins 1

Clinical Significance of Splitting Timing

The timing of egg splitting has significant implications for pregnancy outcomes and management:

  • Monochorionic twins (resulting from splitting at 4+ days) represent about 20% of twin pregnancies but account for 30% of all complications 1

  • Monochorionic-diamniotic twins have approximately 10% mortality rate, primarily related to twin-twin transfusion syndrome (TTTS) and discordant fetal anomalies 1

  • Monochorionic-monoamniotic twins (approximately 1% of monozygotic twins) have historically had high mortality rates (46-64%), though recent studies show improved survival rates >90% with early diagnosis and surveillance 1

Vascular Complications in Monochorionic Twins

The shared placenta in monochorionic twins creates unique complications:

  • Vascular anastomoses are present in over 95% of monochorionic twins, connecting the fetal circulations 1

  • These connections can lead to complications such as:

    • Twin-twin transfusion syndrome (TTTS)
    • Twin anemia-polycythemia syndrome (TAPS)
    • Twin reversed arterial perfusion (TRAP) sequence 1

Monitoring and Management

The type of twinning determined by splitting timing affects pregnancy monitoring:

  • All twin pregnancies typically undergo more ultrasound examinations than singleton pregnancies 1

  • Monochorionic twins require more intensive monitoring due to their higher risk profile 1

  • First trimester ultrasound is crucial for determining chorionicity and amnionicity 1

Embryological Perspective

From a developmental biology standpoint:

  • The zygote forms immediately after fertilization and begins dividing within hours 2

  • Initially, the dividing cells are totipotent (capable of forming all cell types) 2

  • Around day 4, cells begin to specialize to form the blastocyst 2

  • The blastocyst consists of an outer cell layer (future placenta) and inner cell mass (future embryo) 2

Conclusion

The timing of egg splitting after fertilization is the primary determinant of the type of monozygotic twins that develop. This timing has significant implications for placentation, amniotic sac development, and ultimately for pregnancy outcomes and management strategies.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Fertilization and Embryo Development

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.